{"version":"1.0","type":"link","title":"OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer.","author_name":"Rugo HS 외","author_url":"https://prs-insight.online/author/Rugo%20HS","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/79441","thumbnail_width":1200,"thumbnail_height":630}